Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Improving Peptide-Spectrum Matching by Fragmentation Prediction Using Hidden Markov Models.

Kirik U, Refsgaard JC, Jensen LJ.

J Proteome Res. 2019 Jun 7;18(6):2385-2396. doi: 10.1021/acs.jproteome.8b00499. Epub 2019 May 22.

PMID:
31074280
2.

In Vitro Evolution of Antibodies Inspired by In Vivo Evolution.

Persson H, Kirik U, Thörnqvist L, Greiff L, Levander F, Ohlin M.

Front Immunol. 2018 Jun 21;9:1391. doi: 10.3389/fimmu.2018.01391. eCollection 2018.

3.

Antibody Heavy Chain Variable Domains of Different Germline Gene Origins Diversify through Different Paths.

Kirik U, Persson H, Levander F, Greiff L, Ohlin M.

Front Immunol. 2017 Nov 13;8:1433. doi: 10.3389/fimmu.2017.01433. eCollection 2017.

4.

Data on haplotype-supported immunoglobulin germline gene inference.

Kirik U, Greiff L, Levander F, Ohlin M.

Data Brief. 2017 Jun 27;13:620-640. doi: 10.1016/j.dib.2017.06.031. eCollection 2017 Aug.

5.

Parallel antibody germline gene and haplotype analyses support the validity of immunoglobulin germline gene inference and discovery.

Kirik U, Greiff L, Levander F, Ohlin M.

Mol Immunol. 2017 Jul;87:12-22. doi: 10.1016/j.molimm.2017.03.012. Epub 2017 Apr 4.

6.

Molecular Portrait of Breast-Cancer-Derived Cell Lines Reveals Poor Similarity with Tumors.

Cifani P, Kirik U, Waldemarson S, James P.

J Proteome Res. 2015 Jul 2;14(7):2819-27. doi: 10.1021/acs.jproteome.5b00375. Epub 2015 Jun 22.

PMID:
26055192
7.

Discovery-based protein expression profiling identifies distinct subgroups and pathways in leiomyosarcomas.

Kirik U, Hansson K, Krogh M, Jönsson M, Nilbert M, James P, Carneiro A.

Mol Cancer Res. 2014 Dec;12(12):1729-39. doi: 10.1158/1541-7786.MCR-14-0072. Epub 2014 Jul 28.

8.

Multimodel pathway enrichment methods for functional evaluation of expression regulation.

Kirik U, Cifani P, Albrekt AS, Lindstedt M, Heyden A, Levander F.

J Proteome Res. 2012 May 4;11(5):2955-67. doi: 10.1021/pr300038b. Epub 2012 Apr 21.

PMID:
22471554
9.

Protein expression changes in ovarian cancer during the transition from benign to malignant.

Waldemarson S, Krogh M, Alaiya A, Kirik U, Schedvins K, Auer G, Hansson KM, Ossola R, Aebersold R, Lee H, Malmström J, James P.

J Proteome Res. 2012 May 4;11(5):2876-89. doi: 10.1021/pr201258q. Epub 2012 Apr 17.

PMID:
22471520

Supplemental Content

Support Center